At the 10th International Conference on Health and Hepatitis in Substance Users, held in Glasgow, Scotland, international policymakers gathered to discuss the global overdose crisis and the role that supervised consumption sites can play in helping end these needless and preventable deaths.

The policy brief

A new policy brief is now available that summarises the day’s discussions and provides a starting point for those wanting to know more about supervised consumption rooms and their impact.

It includes:

• Evidence of success
• Global case studies
• Evaluation models 
• Implementatio...

Integrating HIV-related care with treatment for substance use disorder provides an opportunity to better meet the needs of people living with these conditions. People with substance use disorder are rendered especially vulnerable by prevailing policies, structural inequalities, and stigmatisation.

In this Series paper, the authors analyse existing literature and empirical evidence from scoping reviews on integration designs for the treatment of HIV and substance use disorder, to understand barriers to and facilitators of care integration and to map ways forward.

They discuss how...

This side event for the 65th Commission on Narcotic Drugs was originally presented on 14 March, 2022. Organised by INPUD, it was co-sponsored by Médecins du Monde, UNAIDS, UNODC HIV/AIDS Section, the Netherlands and Australia.

In 2021, thanks to significant advocacy work by people who use drugs and other key population networks, both the Global AIDS Strategy 2022-2026 and the 2021 Political Declaration on HIV and AIDS committed Member States to fulfill bold new targets on ‘social enablers’ which have significant implications concerning drug policy.

This event reviewed this advocacy work...

The 2021-2026 Global AIDS Strategy has bold and critical new targets on realizing human rights, reducing stigma, discrimination and violence and removing harmful punitive laws as a pathway to ending inequalities and ultimately ending AIDS.

To aid in the scale-up of interventions to remove these societal barriers, UNAIDS has produced a series of fact sheets on human rights in various areas, highlighting the critical need to scale up action on rights. 

This factsheet provides an overview of the latest data, shares information on human rights, and describes the global targets and standards...

Sharing drug injecting equipment increases the risk of transmitting and acquiring blood-borne infections, such as HIV and hepatitis B and C. While hepatitis C is the most prevalent blood-borne viral infection among people who inject drugs (PWID), injecting drug use remains an important mode of HIV transmission in some EU countries, and local outbreaks continue to occur. Despite falling HIV transmission rates in recent years, more than 1 in 10 new AIDS cases in the EU are still attributed to injecting drug use. This may signal late diagnosis or poor case management, both of which are avoidable...

BACKGROUND:

The high prevalence of HIV and substance use disorders (SUD) in Ukraine remains a significant public health problem. A well-trained, recovery-oriented national workforce to enhance SUD treatment associated with HIV care is needed to reduce substance use and HIV-related burden in the country.

METHODS:

The Ukraine Addiction Transfer Technology Center (Ukraine ATTC) was established in 2017 to provide training and technical assistance on the intersection of HIV and SUD to support efforts to control the HIV epidemic in Ukraine. Data were derived from Ukraine ATTC initiatives in...

Este artículo explora las lecciones aprendidas durante la implementación de un proyecto de pruebas de hepatitis C y acceso al tratamiento facilitado por pares llamado proyecto Live Hep C Free para contribuir a los esfuerzos de microeliminación.

El proyecto Live Hep C Free tiene como objetivo facilitar el acceso a las pruebas, el tratamiento y la atención del virus de la hepatitis C en el lugar en entornos prioritarios a través de una asociación entre un compañero trabajador y una enfermera clínica. Desde el inicio del proyecto en enero de 2018, 4515 personas se involucraron con el virus de...